Predictive factors of pathological complete response by neoadjuvant chemotherapy for operable breast cancer

被引:0
|
作者
Ishikawa, Takashi [1 ]
Shimizu, Daisuke [1 ]
Sasaki, Takashi [1 ]
Morita, Satoshi [1 ]
Tanabe, Mikiko [1 ]
Ota, Ikuko [1 ]
Kawachi, Kae [1 ]
Chishima, Takashi [2 ]
Ichikawa, Yasushi [2 ]
Endo, Itaru [2 ]
机构
[1] Yokohama City Univ, Med Ctr, Yokohama, Kanagawa 232, Japan
[2] Yokohama City Univ, Yokohama, Kanagawa 232, Japan
关键词
D O I
10.1158/1538-7445.AM2011-304
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
304
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Clinical and pathological factors predictive of response to neoadjuvant chemotherapy in breast cancer: A single center experience
    Del Prete, Salvatore
    Caraglia, Michele
    Luce, Amalia
    Montella, Liliana
    Galizia, Gennaro
    Sperlongano, Pasquale
    Cennamo, Gregorio
    Lieto, Eva
    Capasso, Elena
    Fiorentino, Olga
    Aliberti, Maria
    Auricchio, Annamaria
    Iodice, Patrizia
    Addeo, Raffaele
    [J]. ONCOLOGY LETTERS, 2019, 18 (04) : 3873 - 3879
  • [22] Body Mass Index as a Predictive Factor of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
    Bellet Ezquerra, M.
    Perez Garcia, J. M.
    Munoz Couselo, E.
    SauraManich, C.
    Gomez Pardo, P.
    Vidal, M.
    Argiles, G.
    De Mattos, L.
    Cortes Castan, J.
    Baselga Torres, J.
    [J]. CANCER RESEARCH, 2010, 70
  • [23] Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy
    Toss, Angela
    Venturelli, Marta
    Civallero, Monica
    Piombino, Claudia
    Domati, Federica
    Ficarra, Guido
    Combi, Francesca
    Cabitza, Eleonora
    Caggia, Federica
    Barbieri, Elena
    Barbolini, Monica
    Moscetti, Luca
    Omarini, Claudia
    Piacentini, Federico
    Tazzioli, Giovanni
    Dominici, Massimo
    Cortesi, Laura
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [24] Predictive factors of response to anthracylines neoadjuvant chemotherapy in breast cancer
    Bensouda, Y.
    Ismaili, N.
    Ahbeddou, N.
    El Hassani, K.
    Chenna, M.
    Sbitti, Y.
    Boutayeb, S.
    Errihani, H.
    [J]. GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2011, 39 (02): : 81 - 86
  • [25] PREDICTIVE FACTORS OF NO RESPONSE DURING NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER
    Jo, J.
    Yoo, C.
    Kim, J. -E.
    Ahn, J. -H.
    Kim, S. -B.
    Kim, H. -H.
    Cha, J. H.
    Shin, H. J.
    Ahn, S. -H.
    Son, B. H.
    Lee, J. W.
    Kim, H. J.
    Gong, G.
    Jung, K. H.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 40 - 40
  • [26] Neoadjuvant chemotherapy of operable breast cancer with single-agent epirubicin: efficacy and predictive factors for response.
    Budd, G. T.
    Tubbs, R. R.
    Crowe, J.
    Weng, D.
    Moore, H.
    Cook, R.
    Swain, E.
    Prescott, N.
    Pettay, J.
    Tarr, S.
    Hicks, D.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S155 - S156
  • [27] Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer
    Chollet, P
    Amat, S
    Cure, H
    de Latour, M
    Le Bouedec, G
    Mouret-Reynier, MA
    Ferriere, JP
    Achard, JL
    Dauplat, J
    Penault-Llorca, F
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (07) : 1041 - 1046
  • [28] Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer
    Chollet P.
    Amat S.
    Cure H.
    De Latour M.
    Le Bouedec G.
    Mouret-Reynier M.-A.
    Ferriere J.-P.
    Achard J.-L.
    Dauplat J.
    Penault-Llorca F.
    [J]. British Journal of Cancer, 2002, 86 (7) : 1041 - 1046
  • [29] Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy
    Jie Dong
    Qingqing Sun
    Yueyin Pan
    Nannan Lu
    Xinghua Han
    Qiong Zhou
    [J]. BMC Cancer, 21
  • [30] Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy
    Dong, Jie
    Sun, Qingqing
    Pan, Yueyin
    Lu, Nannan
    Han, Xinghua
    Zhou, Qiong
    [J]. BMC CANCER, 2021, 21 (01)